Menu
Back to Journals » OncoTargets and Therapy » Volume 11
Original Research
Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,876 | Dovepress* | 8,171+ | 1,016 | 9,187 | |
| PubMed Central* | 1,705 | 384 | 2,089 | ||
| Totals | 9,876 | 1,400 | 11,276 | ||
| *Since 19 April 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 3 | 0 | 0 | 0 | 1 | 2 |
View citations on PubMed Central and Google Scholar